Towards Healthcare
Disease Management Apps Market

Disease Management Apps Market Fueling Connected Health

Based on market forecasts, the disease management apps sector will expand from USD 11.30 billion in 2025 to USD 30.25 billion by 2035, experiencing a CAGR of 10.35%.The rising prevalence of chronic disorders and the growing demand for telemedicine drive the global market. North America dominated the global market due to a robust healthcare infrastructure and favorable regulatory support.

Last Updated : 12 December 2025 Category: Healthcare IT Insight Code: 6502 Format: PDF / PPT / Excel
next-arrow
Revenue, 2025
11.30 Billion
next-arrow
Forecast, 2035
30.25 Billion
next-arrow
CAGR, 2026 – 2035
10.35%
next-arrow
Report Coverage
Global

Disease Management Apps Market Size, Insights and Shares with Key Players

The global disease management apps market size was estimated at USD 11.30 billion in 2025 and is predicted to increase from USD 12.47 billion in 2026 to approximately USD 30.25 billion by 2035, expanding at a CAGR of 10.35% from 2026 to 2035.

Disease Management Apps Market Trends and Growth (2026)

The disease management apps market is primarily driven by the rising adoption of advanced technologies and the growing demand for patients to take part in the clinical decision-making process. The increasing smartphone and internet penetration and the rising healthcare consumerization favor market growth. Government bodies also support the use of telehealth through initiatives and funding.

Key Takeaways

  • Disease management apps industry poised to reach USD 12.47 billion by 2026.
  • Forecasted to grow to USD 30.25 billion by 2035.
  • Expected to maintain a CAGR of 10.35% from 2026 to 2035.
  • North America held a major revenue share of 35% in the market in 2025.
  • Asia-Pacific is expected to witness the fastest growth during the predicted timeframe.
  • By product type, the diabetes management apps segment accounted for the highest revenue share of 35% in the disease management apps market in 2025.
  • By product type, the cardiovascular disease apps segment is expected to grow with the highest CAGR in the market during the studied years.
  • By deployment type, the cloud-based segment contributed the biggest revenue share of 60% in the market in 2025.
  • By deployment type, the hybrid (cloud + local) segment is expected to expand rapidly in the market in the coming years.
  • By application, the remote patient monitoring segment held a dominant revenue share of 40% in the market in 2025.
  • By application, the medication & treatment adherence segment is expected to witness the fastest growth in the disease management apps market over the forecast period.
  • By end-user, the hospitals & health systems segment led the market with a share of 40% in 2025.
  • By end-user, the individual patients/consumers segment is expected to grow at the fastest CAGR in the market during the forecast period.

Key Indicators and Highlights

Key Elements Scope
Market Size in 2026 USD 12.47 Billion
Projected Market Size in 2035 USD 30.25 Billion
CAGR (2026 - 2035) 10.35%
Leading Region North America by 35%
Market Segmentation By Product Type, By Deployment Type, By Application, By End-User, By Region
Top Key Players Omada Health, Inc., WellDoc, Teladoc Health, Glooko, Medtronic Care Management Services, Philips Healthcare, Proteus Digital Health, Dexcom, Inc., ADA Health, MyFitnessPal

The disease management apps market refers to the global ecosystem of mobile and web-based digital health applications designed to help patients monitor, manage, and treat chronic and acute health conditions. These apps perform numerous functions, such as symptom tracking, medication reminders, remote monitoring of vitals, lifestyle and behavioral guidance, teleconsultation integration, and data sharing with healthcare providers. They aim to improve disease outcomes, patient adherence, and overall quality of care by enabling continuous health monitoring, self-management, and timely intervention.

AI plays a vital role in promoting and supporting self-management in patients with chronic conditions. AI and machine learning (ML) algorithms analyze vast amounts of patient data, enabling disease detection, improving diagnostic accuracy, and providing patient-centered care. They improve the quality and access to care, reduce costs, and optimize daily self-management by integrating with clinical information systems and patient-facing technologies. Natural language processing (NLP) helps identify patients’ conditions in real time through texts and voice-based agents.

  • Increasing Smartphone Penetration: Smartphones are increasingly used across the globe and provide the benefit of at-home self-management. As of 2024, 4.88 billion people use smartphones globally.
  • Personalized Care: The growing demand for personalized and accessible care drives the use of digital health. Digital apps offer personalized treatment plans, helping patients manage their conditions effectively.
  • Smart Wearables: AI-enabled sensors in wearable devices provide real-time health information to clinicians and enhance the effectiveness of lifestyle interventions.

A Global Snapshot of Chronic Disease Burden

Chronic Disease Prevalence Rate

Countries Total Population Affected by Chronic Disease
India 21%
Australia 50%
Germany 53.7%
UAE 60%
Brazil 45%

Global Guardians of Digital Care: WHO & Governments Drive App Adoption

  • The World Health Organization (WHO)’s Global Strategy on Digital Health 2020-2027 aims to promote healthy lives and well-being for everyone and support countries in strengthening their health systems.
  • In July 2025, the Trump Administration secured the backing of over 60 leading healthcare and technology companies for an initiative to make personal medical data more accessible to U.S. consumers via digital devices.
  • The German government has established a Digital Healthcare Act to support the integration of digital health solutions into the healthcare system and regulate the Digital Health Applications.

Segmental Insights

Which Product Type Segment Dominated the Disease Management Apps Market?

Diabetes Management Apps

The diabetes management apps segment held a dominant position in the market in 2025, with a revenue of 35% due to the rising prevalence of diabetes and growing awareness of preventive diabetes care. Diabetes management apps facilitate blood glucose tracking, insulin dose calculation, and diet and lifestyle management. They are widely preferred as people are aware of avoiding potential diabetes complications. The International Diabetes Federation (IDF) reported that 589 million people were suffering from diabetes in 2024.

Cardiovascular Disease Apps

The cardiovascular disease apps segment is expected to grow at the fastest CAGR in the market during the forecast period. Cardiovascular diseases (CVDs) are the most common causes of morbidity and mortality, especially among the geriatric population, globally. CVD apps enable patients and healthcare professionals to assess future risks and monitor vital parameters, such as blood pressure, heart rate, and oxygen saturation.

How the On-Premise/Local Installations Segment Dominated the Disease Management Apps Market?

Cloud-based

The cloud-based segment held the largest revenue share of the market in 2025, with a revenue of 60%. Cloud-based tools can store large amounts of data and can be accessed by providers from anywhere and at any time. They offer superior advantages, such as high flexibility and scalability. They allow companies to pay on an as-needed basis and effectively scale up or down based on overall usage.

Hybrid (Cloud + Local)

The hybrid (cloud + local) segment is expected to grow with the highest CAGR in the market during the studied years. Hybrid systems blend the benefits of cloud-based and on-premise tools, providing high flexibility in a healthcare organization. They also offer high scalability and cost control for healthcare professionals. They provide more deployment options, security, compliance, and get more value from their existing infrastructure.

Which Application Segment Led the Disease Management Apps Market?

Remote Patient Monitoring

The remote patient monitoring segment led the market in 2025, with a revenue of 40% due to the burgeoning telehealth sector and the growing geriatric population. Disease management apps eliminate the need for patients to visit any healthcare organization physically and receive advanced care from the comfort of their homes. This saves a lot of time and costs for patients. Healthcare professionals also benefit from apps by providing tailored insights and serving a larger patient population.

Medication & Treatment Adherence

The medication & treatment adherence segment is expected to expand rapidly in the market in the coming years. Disease management apps are leveraged by AI-based sensors to continuously track patients. They provide real-time notifications of patients’ health status and send reminders for timely drug use. They enhance medication adherence through certain interventions, such as short message service and electronic pillboxes.

What Made Hospitals & Health Systems the Dominant Segment in the Disease Management Apps Market?

Hospitals & Health Systems

The hospitals & health systems segment contributed the biggest revenue share of 40% of the market in 2025, due to favorable infrastructure and rising patient volumes. Patients prefer hospitals due to the presence of multidisciplinary expertise and favorable reimbursement policies. Hospitals and health systems receive funding from the government and private organizations to adopt advanced digital health tools. They can help providers treat a vast patient population across diverse geographical locations.

Individual Patients/Consumers

The individual patients/consumers segment is expected to witness the fastest growth in the market over the forecast period. People are becoming more aware of disease management apps and their benefits. Patients are also aware of their health and fitness, necessitating them to continuously track their vital parameters. The increasing use of wearable devices also contributes to the segment’s growth.

Regional Distribution

Disease Management Apps Market Share, By Region, 2025 (%)

  • North America registered dominance in the disease management apps market in 2025, with a 35% share.
  • The U.S. led the market by capturing the largest revenue share in 2025.
  • Asia Pacific is expected to be the fastest-growing region in the studied years.
  • China is anticipated to grow at a rapid CAGR during the forecast period.
  • Europe is expected to grow at a significant CAGR during the forecast period.
  • The UK is anticipated to grow at a rapid CAGR over the upcoming years.

North America dominated the global market in 2024, with a revenue of 35%. The presence of a robust healthcare infrastructure, the rising prevalence of chronic disorders, and favorable regulatory support are the major factors that govern market growth in North America. The increasing use of wearable devices and the presence of key players foster market growth. Additionally, government bodies in North America make constant efforts to create a more robust digital health ecosystem.

According to a recent consumer study in the U.S., approximately 50% of 8,000 U.S. internet households own and actively use wearable devices, underscoring the growing demand for health and safety features. There are a total of 261,500 digital health apps in the U.S. that focus on chronic disease management. Key players, such as Odama Health, Teladoc Health, and Philips Healthcare, are major contributors to the market in the U.S.

Asia-Pacific is expected to grow at the fastest CAGR in the market during the forecast period. The growing geriatric population and the burgeoning healthcare sector propel the market. Government organizations launch initiatives to support the adoption of digital tools within the healthcare sector. They also provide funding to healthcare organizations and reimbursement to patients. The increasing use of mobile health apps and growing awareness of digital health apps in remote locations also boost market growth.

China’s digital healthcare ecosystem is booming, driven by government initiatives and the growing demand for personalized care. It is estimated that approximately 81.1% of the total Chinese population has at least one chronic disease, representing 179.9 million older adults.  The nation spends around 7% of its GDP on health, promoting the adoption of digital tools.

Europe is expected to grow at a considerable CAGR in the upcoming period. The increasing adoption of advanced technologies and rising investments augment the market. The European Centre for Disease Prevention and Control offers surveillance and outbreak tools to support and guide outbreak preparedness, investigation, and response activities. Increasing collaborations among key players and public-private partnerships facilitate the development of innovative disease management apps in the region.

There are around 227,500 digital health apps in the UK. The UK government supports cutting-edge tech projects, leading to the development of digital tools. Innovate UK is supporting 17 businesses, including the development of light-weight smart glasses which use AI to address the impact of illnesses like depression, anxiety, and psychosis.

Mobile Health Apps Usage (Out of 147 Participants)

Mobile Health App Usage Percentage of Users (out of 147 participants) 
Daily Users 40%
Weekly Users 24.39%
Occasional Users 14.63%

 

Top Companies & Their Offerings in the Disease Management Apps Market

Disease Management Apps Market Key Players

Companies Headquarters Offerings
Omada Health, Inc. California, United States It offers virtual care solutions with personalized chronic disease management programs.
WellDoc Maryland, United States WellDoc App supports prediabetes, diabetes, heart failure, hypertension, and weight management.
Teladoc Health New York, United States Teladoc Health is a telemedicine platform that promotes physical, mental, and emotional well-being in a practical and safe way.
Glooko California, United States Glooko Mobile App helps users stay connected and collaborate with their care teams between visits, identify trends, and share reports remotely.
Medtronic Care Management Services Minneapolis, United States It offers Medtronic CareLink, MyCareLink, and MyCareLink Smart applications for remote patient monitoring.
Philips Healthcare Massachusetts, United States The Philips Care Assist mobile app transforms qualified smart devices into a powerful tool for caregivers working in fast-paced hospital environments.
Proteus Digital Health California, United States It offers apps that track medication use and health status from smartphones and help patients receive reminders and alerts.
Dexcom, Inc. California, United States The Dexcom Clarity App allows patients to measure their glucose trends and time in range, enabling them to track their progress.
ADA Health Berlin, Germany The app assesses answers against its medical dictionary of thousands of disorders and medical conditions and provides a personalized report to patients.
MyFitnessPal Texas, United States It is a nutrition tracking app that helps people reach their health, fitness, and weight goals.

SWOT

Strengths

    • The rising prevalence of chronic disorders due to the growing geriatric population and sedentary lifestyles potentiates the use of disease management apps.
    • The growing demand for personalized and remote care enables healthcare professionals to treat multiple patients effectively.
    • Increasing smartphone and internet penetration allows patients to receive personalized care from a distant location.

Weaknesses

    • Some people from underdeveloped and developing countries are unaware of advanced mobile health apps for disease management.
    • The high cost of disease management apps makes it unaffordable for patients from low- and middle-income groups. The average cost of health apps ranges from $100,000 to $500,000.

Opportunities

    • The integration of AI, analytics, and wearable device data into disease management presents future opportunities for the market.
    • Government initiatives to promote the digitization of healthcare drive the future.

Threats

    • The data privacy challenges raise concerns about data leakage among patients, limiting their widespread use.
    • Mobile health apps in some countries are treated as medical devices, and in some countries, they fall outside stringent regulation requirements.

Recent Developments in the Disease Management Apps Market

  • In September 2025, EletronRx announced the launch of the pDx app to measure lung function at home using a mobile phone, tablet, or laptop. The app enables clinicians to remotely assess cardiopulmonary function, track disease progression, and adjust treatment protocols to optimize therapeutic outcomes.
  • In February 2025, Lillia, an AI startup for chronic care, launched its platform for individuals living with diabetes and other chronic conditions. The AI-powered app guides patients in developing long-lasting micro-habits, backed by proven clinical outcomes.

Segments Covered in the Report

By Product Type

  • Diabetes Management Apps
    • Blood glucose tracking
    • Insulin dose calculators
  • Cardiovascular Disease Apps
    • Heart rate monitoring
    • Blood pressure tracking
  • Respiratory Disease Apps
    • Asthma management
    • COPD monitoring
  • Mental Health & Wellness Apps
    • Mood tracking
    • Therapy/meditation integration
  • Other Disease Management Apps
    • Chronic kidney disease
    • Obesity & weight management

By Deployment Type

  • On-Premise/Local Installations
  • Cloud-based
  • Hybrid (Cloud + Local)

By Application

  • Remote Patient Monitoring
  • Medication & Treatment Adherence
  • Patient Engagement & Education
  • Data Analytics & Health Insights
  • Other Applications

By End-User

  • Hospitals & Health Systems
  • Individual Patients/Consumers
  • Pharmaceutical & Biotech Companies
  • Insurance & Payers
  • Other End-Users

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA
FAQ's

The disease management apps market is projected to reach USD 11.30 billion by 2035, growing at a CAGR of 10.35% from 2026 to 2035.

North America is leading the disease management apps market by 35% due to the presence of a robust healthcare infrastructure and favorable regulatory support.

The disease management apps market includes five segments: by product type, by deployment type, by application, by end-user, and by region.

A chronic care management platform is an application through which care for patients with chronic health conditions can be delivered and coordinated.

World Health Organization, Press Information Bureau, European Centre for Disease Prevention and Control, GOV.UK

Tags

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Recently Viewed Reports

Related Reports